首页> 美国卫生研究院文献>Clinical Molecular Pathology >Detection of telomerase its components and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia
【2h】

Detection of telomerase its components and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia

机译:检测宫颈刮片中的端粒酶端粒酶和人类乳头瘤病毒作为诊断宫颈发育不良妇女的工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: To examine whether the detection of either telomerase and its components or high risk human papillomavirus (HPV) are of value in predicting the presence of cervical intraepithelial neoplasia (CIN) grade II/III in women referred because of cervical cytology reports showing at most moderate dyskaryosis.>Methods: Cervical scrapings of 50 women referred with cytological borderline, mild, or moderate dyskaryosis were analysed. Telomerase activity was assessed by a commercially available telomere repeat amplification protocol assay and its components human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) were assessed by reverse transcriptase polymerase chain reaction (PCR). HPV was detected by GP5+/6+ PCR enzyme immunosassay. Histological findings on colposcopy guided biopsies or excised cervical tissue were regarded as the final pathological diagnosis. The sensitivity and specificity for detecting CIN II/III were calculated.>Results: Twenty eight women were diagnosed with CIN II/III. Telomerase activity was detected in none, hTR in 88%, hTERT in 23%, and high risk HPV was detected in 79% of these women. As a diagnostic test none of the described analyses combined a sensitivity of at least 90% with a specificity ≥ 90%. Despite the small numbers, calculation of the 95% confidence intervals excluded a combined sensitivity and specificity of at least 90% for all of the evaluated parameters.>Conclusions: Neither detection of telomerase or its components, nor detection of high risk HPV seem suitable for the triage of women with borderline, mild, and moderate cytological dyskaryosis.
机译:>目标:研究检查端粒酶及其成分或高危型人乳头瘤病毒(HPV)的检测是否对预测所提及的女性宫颈上皮内瘤变(CIN)II / III级是否有价值,因为>方法:分析了50例因细胞学性边界,轻度或中度旋律障碍而被转诊的妇女的宫颈刮擦情况。端粒酶活性通过可商购的端粒重复扩增方案分析进行评估,其组成成分人端粒酶RNA(hTR)和人端粒酶逆转录酶(hTERT)通过逆转录酶聚合酶链反应(PCR)进行评估。通过GP5 + / 6 + PCR酶免疫法检测HPV。阴道镜引导下的活检或切除的宫颈组织的组织学发现被认为是最终的病理诊断。计算了检测CIN II / III的敏感性和特异性。>结果:诊断为CIN II / III的女性有28名。在这些女性中,没有检测到端粒酶活性,hTR为88%,hTERT为23%,高风险HPV被检测到。作为诊断测试,所有上述分析均未结合至少90%的敏感性和90%以上的特异性。尽管数量少,但对所有评估参数的95%置信区间的计算都排除了至少90%的综合敏感性和特异性。>结论:既不检测端粒酶或其成分,也不检测高危型HPV似乎适合对边缘性,轻度和中度细胞学上的旋律不稳的女性进行分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号